Brief: Enorama Pharma Enters Into Agreement With Habit Factory
07/03/2025 07:19
March 7 (Reuters) - Enorama Pharma AB ERMA.ST: SAID ON THURSDAY ENTERED INTO JOINT LICENSE AGREEMENT WITH HABIT FACTORY NORDEN AB LICENSE AGREEMENT GRANTS HABIT FACTORY RIGHT TO USE ENORAMA PHARMA'S TOBACCO-FREE WHITE SNUS BOTH FOR PRODUCTION AND SALE IN THE US Source text for Workspace: nWkr3g9zX2 Further company coverage: [ERMA.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO